FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition comprising benzamide derivative represented by the formula (1)
or its pharmaceutically acceptable salt and one or more substances taken among D-mannitol, carboxymethylstarch sodium, hydroxypropylcellulose, magnesium stearate, partially gelatinized starch, hydroxypropylmethylcellulose, dimethylacetamide, sodium carbonate, potassium carbonate, ammonium carbonate, sodium hydrocarbonate, potassium hydrocarbonate, sodium hydroxide, sodium hydrogen phosphate, ammonium, monosubstituted sodium fumarate, sodium dehydroacetate, sodium erythorbate, trisubstituted sodium citrate and amine. The composition elicits the enhanced stability.
EFFECT: improved and valuable pharmaceutical properties of composition.
5 cl, 8 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL MEDICAL FORM OF ATORVASTATIN | 2005 |
|
RU2395280C2 |
| PHARMACEUTICAL COMPOSITION BASED ON CONDENSED DERIVATIVE OF AMINODIHYDROTHIAZINE | 2015 |
|
RU2710227C2 |
| ORAL PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2639473C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE DERIVATIVE | 2010 |
|
RU2548673C2 |
| PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2470637C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING SODIUM ALKYL SULPHATE | 2019 |
|
RU2759746C1 |
| OBTAINING A TETRACYCLIC COMPOUND CONTAINED IN A HIGH DOSE | 2015 |
|
RU2724056C2 |
| PHARMACEUTICAL SOLID PREPARATION CONTAINING BENZAZEPIN AND METHOD FOR PREPARING IT | 2008 |
|
RU2466717C2 |
| CALCIUM BLOCKING AGENT-CONTAINING STABILIZED PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2239432C2 |
| METHOD OF INCREASING EFFICIENCY OF THERAPY OF AUTOIMMUNE DISEASES, SUCH AS RHEUMATOID ARTHRITIS | 2012 |
|
RU2611341C2 |
